The Role of LZTS3 in Colon Cancer
Author Information
Author(s): Ye Kui, Cao Huaxiang, Xu Zihao, Liu Peng, Jiang Xueying, Liu Qiancheng, Yang Hongquan, Huo Menghua, Wang Teng, Wang Jian
Primary Institution: Wuxi Second Geriatric Hospital
Hypothesis
LZTS3 has an oncogenic role in colorectal adenocarcinoma (COAD).
Conclusion
LZTS3 expression is significantly elevated in COAD and is associated with advanced disease stages and poorer clinical outcomes.
Supporting Evidence
- LZTS3 was found to be overexpressed in COAD samples compared to normal tissues.
- High LZTS3 expression was significantly associated with worse overall survival in COAD patients.
- Gene enrichment analyses indicated that LZTS3 may play roles in tumor progression.
- LZTS3 expression correlates with immune cell distributions in the tumor microenvironment.
Takeaway
Researchers found that a gene called LZTS3 is more active in colon cancer, which might help doctors understand and treat the disease better.
Methodology
The study analyzed mRNA expression levels and clinical data from COAD patients using TCGA datasets.
Limitations
The study is based on bioinformatic analyses and requires further validation in biological models.
Participant Demographics
The study included 483 COAD cases and 41 normal colorectal tissues.
Statistical Information
P-Value
p = 0.003
Confidence Interval
95% CI: 0.913-0.957
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website